Description
I have 2 of my classmates posts. I need you to respond to each one separately. Also, 3 sources at least for each one of them. Don’t write about how good their posts or how bad. All you need to do is to choose one point of the post and explore it a little bit with one source support for each response. The paper should be APA style.- pleas use proper references format and in-line citation.- Minimum words for every respond 300All the details in the attached below
Unformatted Attachment Preview
Question: You are an Emergency Manager in your respective country. A highly infectious
influenza strain has been detected. There is a limited quantity of the vaccine to prevent this
particular strain of influenza. Discuss your plan for distributing this vaccine. Who receives the
vaccine and who does not? How did you come to this conclusion?
First Post: Aziz
Influenza outbreak is a series issue that will affect the whole community negatively. One
proven and effective solution to prevent any influenza (flu) outbreak is the flu vaccination (CDC,
2019). Every year the CDC cooperates with the world health organization (WHO) and the
pharmaceutical companies to make sure that the vaccination is available in amounts that will
cover the public need (FEMA, n.d.). We, as emergency manages, should have a plan to distribute
the vaccinations properly in case of vaccine shortage because it occurred before and it may occur
in the future.
As an emergency manager, I would have to ask myself three questions to determine how
I can distribute the vaccination in case of a shortage. The questions are, who is the most valuable
population in this outbreak? And are there other populations that may get infected as a secondary
wave of this outbreak? Also are there any measures to reduce the transmitting of the virus?
Depending on these questions’ answers, I will distribute the vaccinations. Generally speaking, in
any given flu outbreak, there are three vulnerable populations to the flu the children, people who
above 65 years old, and people who had preexisting conditions (Mungherera, 2014). Due to these
populations’ vulnerability, they will be vaccinated to prevent severe complications that may
overwhelm the system and lead to the patient’s death in some cases (Rothberg, Haessler, &
Brown, 2008).
According to FEMA, the health care providers and peoples who contact with an infected
person directly like the caregivers or the first responders are usually getting infected with the flu
as a second wave to the first flu infection (FEMA, n.d). As an emergency manager, I will include
the health care providers, people who take care of an infected person, and first responders as a
priority in my vaccination distribution plan even if they do not fall in the vulnerable populations’
category. I will add them because when they get infected, they have to stay home, and no one
could fill the gap they created and take care of our sick patients.
As an emergency manager, I will explain to all other populations whey theses populations
are a priority. Further, I will try to encourage the public to apply safety measures like hand
washing, social distancing, staying home if they feel sick, and covering their mounts when they
sneeze (Mayo Clinic, n.d.) to reduce the contingency of this outbreak. I will understand if the
public outrages because of my decision, yet I have to act in the public best interest.
References
CDC. (2019, January 24). What are the benefits of flu vaccination? Retrieved from
https://www.cdc.gov/flu/prevent/vaccine-benefits.htm#:~:targetText=Flu vaccination can reduce
the,estimated 109,000 flu-related hospitalizations.
FEMA. (n.d.). IS-520. Retrieved from https://emilms.fema.gov/IS520/PAN0101000.htm
Mungherera, M. (2014, August 10). Who are the vulnerable groups? Retrieved from
https://preventingtheflu.org/blogs/who-are-the-vulnerable-groups/#:~:targetText=The elderly
(aged >65),, cancer, and heart conditions.
Rothberg, M., B., Haessler, S., D., & Brown, R., B. (2008, April). Complications of Viral
Influenza. Retrieved
from https://www.sciencedirect.com/science/article/abs/pii/S0002934308000727
Second Post: SAL
The influenza vaccine plays an important role in managing the spread of this viral respiratory
infection. Considering that there is no known cure for flu, the vaccine protects one from
contracting the infection by limiting the associated complications. In the event of a limited
quantity of the vaccine to prevent a new influenza strain, the focus should be on reaching all
high-risk groups, such as children and the elderly.
Although evidence shows that vaccinating schoolchildren is the most effective way to limit
transmission of the flu at the community level, an influenza vaccine shortage necessitates even
concentration across all high-risk groups. Upon covering these populations, the focus can then
move on to vaccinating other groups, such as health professionals who regularly come into close
contact with patients (Medlock & Galvani, 2009; Marcello, Papadouka, Misener, Wake,
Mandell, & Zucker, 2014). This model is supported by scientific evidence, which shows that
distributing an influenza vaccine to at least 70% of high-risk groups, such as children, greatly
reduces transmission rates (Araz, Galvani, & Meyers, 2012). Thus, if the available vaccine is
enough to cover the 70% threshold, the new influenza strain will effectively have been
prevented. Based on this observation, when vaccine supply is limited cutting across all high-risk
groups is more effective than focusing on schoolchildren.
Overall, the most effective strategy for distributing a limited influenza vaccine is to concentrate
on high-risk groups. Since humans have limited immunity to any new influenza strain, there is a
need to focus on the group(s) that would cause the greatest burden on the healthcare system in
case of a pandemic. Therefore, targeting decisions must consider the amount of vaccine available
and the size of all high-risk groups.
References
Araz, O., Galvani, A., & Meyers, L. (2012). Geographic prioritization of distributing pandemic
influenza vaccines. Health Care Management Science, 15(3), 175–187.
Marcello, R., Papadouka, V., Misener, M., Wake, E. Mandell, R., & Zucker, J. (2014).
Distribution of pandemic influenza vaccine and reporting of doses administered, New York, New
York, USA. Emerging Infectious Diseases, 20 (4), 525-531.
Medlock, J. & Galvani, A. (2009). Optimizing influenza vaccine
distribution. Science, 325(5948), 1705-1708.
Purchase answer to see full
attachment
